Belladonna And Opium Suppository shortage
Belladonna And Opium Suppository is currently listed in shortage by the FDA. The FDA lists 4 affected products. This page was last refreshed from FDA data on Oct 4, 2026.
Padagis is permanently stopping production of belladonna and opium suppositories. No other manufacturer of this medicine is currently listed as having supply available.
Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available.
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Belladonna And Opium Suppository. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
Jul 23, 2026Currently in shortage4 of 4 products affected.
-
Jul 23, 2026First reported to the FDA4 products first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: Padagis US LLC 📞 (800) 775-2054 4 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| To Be Discontinued | Belladonna and Opium, Suppository, 16.2 mg; 30 mg (NDC 0574-7045-04) | — | — | Discontinuation of the manufacture of the drug | — |
| To Be Discontinued | Belladonna and Opium, Suppository, 16.2 mg; 30 mg (NDC 0574-7045-12) | — | — | Discontinuation of the manufacture of the drug | — |
| To Be Discontinued | Belladonna and Opium, Suppository, 16.2 mg; 60 mg (NDC 0574-7040-04) | — | — | Discontinuation of the manufacture of the drug | — |
| To Be Discontinued | Belladonna and Opium, Suppository, 16.2 mg; 60 mg (NDC 0574-7040-12) | — | — | Discontinuation of the manufacture of the drug | — |
These rows are manufacturer reports to the FDA for Belladonna And Opium Suppository — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Belladonna And Opium Suppository? options further down this page.
Why is Belladonna And Opium Suppository in shortage?
Padagis US LLC has reported that they are permanently stopping the manufacturing of their Belladonna and Opium suppositories — both the 16.2 mg/30 mg and 16.2 mg/60 mg strengths, across all their package sizes. No specific reason was shared publicly for why they made this decision.
It's worth knowing that this report reflects only what Padagis US LLC has filed with the FDA — it covers their products specifically, not every manufacturer of this medication. Other companies may still produce this drug and are listed separately on the FDA's shortage page.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Belladonna And Opium Suppository, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Belladonna And Opium Suppository?
Belladonna and Opium suppositories are currently on the FDA shortage list, and I want to walk you through what that means for you.
Both strengths—16.2 mg/60 mg and 16.2 mg/30 mg—are reported with no available source right now. The manufacturer on this record, Padagis US LLC, has marked these as being discontinued, which means this supply problem may be permanent rather than a temporary gap.
Because the reason given is discontinuation of manufacture, the right next step is a conversation with your prescriber. Please don't let this news worry you into changing anything on your own.
Here is how I'd suggest moving forward:
- Do not stop, skip, or change your dose on your own. Keep taking your medicine as prescribed while you sort out next steps.
- Ask your pharmacy to check their wholesalers—local stock sometimes differs from national reports, and they can confirm what's truly available.
- Because this product is being discontinued, talk with your prescriber or pharmacist about a suitable alternative they can choose for your situation.
The manufacturer's contact number is listed on this page for reference, though your pharmacy usually handles those calls. This is general information from national FDA data and may not match your local pharmacy's actual stock.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
- This is a controlled substance. Transfers between pharmacies and switching strengths have extra federal/state rules — ask the pharmacy before you assume a transfer is possible.
Therapeutic equivalents & pricing 4 productsclick to expand
Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| Belladonna and Opium 16.2 mg/1; 30 mg | Padagis | 4 suppositories | — | — | FDA listed |
| Belladonna and Opium 16.2 mg/1; 30 mg | Bryant | 4 suppositories | — | — | FDA listed |
| Belladonna and Opium 16.2 mg/1; 30 mg | Padagis | 12 suppositories | — | — | FDA listed |
| Belladonna and Opium 16.2 mg/1; 60 mg | Padagis | 4 suppositories | — | — | FDA listed |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Other drugs in the same treatment class
These are different medicines — not other versions of Belladonna And Opium Suppository — that fall in the same broad treatment class (opioid analgesics) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Identity & classification
Where does this data come from?
Other analgesia/addiction shortages
Belladonna And Opium Suppository shortage FAQs
Is Belladonna And Opium Suppository in shortage?
Which products are affected?
When will Belladonna And Opium Suppository be available again?
What should I do if I take Belladonna And Opium Suppository?
Still have a question about the Belladonna And Opium Suppository shortage?
Ask a pharmacist about this shortage →View Belladonna And Opium Suppository on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.